Many people who get COVID-19 recover physically but struggle mentally. They call it “brain fog.” It feels like your thoughts are moving through mud. Simple tasks take longer. Words get stuck. A new study tests a digital tool that might spot these problems faster than ever before.
Post-COVID-19 condition (PCC), often called long COVID, affects millions. About 1 in 5 adults who had COVID report lingering symptoms. Brain fog is one of the most common and frustrating. It can hurt work, school, and daily life.
Current cognitive tests are often long and tiring. They require a clinic visit and a trained specialist. For someone already exhausted, this is a big barrier. We need faster, easier ways to check brain function.
The old way vs. the new way
Traditionally, doctors use paper-and-pencil tests or long computer sessions. These can take hours. They are the gold standard but are hard to access.
But here’s the twist: a new study is testing a tablet-based tool called VMTech. It aims to give quick, reliable results. The goal is to match the accuracy of longer tests in a fraction of the time.
Think of your brain like a busy city. Cognitive tests are like traffic sensors. They check if information flows smoothly or if there’s a jam.
The VMTech device is a new sensor. It uses short, game-like tasks on a tablet. These tasks measure memory, attention, and speed. The idea is to get a clear picture of brain traffic without a long commute to the clinic.
The study will compare this digital tool to standard tests. It’s like checking a new thermometer against a trusted old one.
The DigiCog study is happening in Luxembourg. It includes adults aged 25 to 65. Some have persistent COVID symptoms, and some do not. Trained nurses and neuropsychologists give both the VMTech test and standard cognitive tests. They also collect data on fatigue, mood, and other factors.
The study is cross-sectional, meaning it’s a snapshot in time. It’s part of a larger cohort study on COVID-19.
This is a protocol study, so results are not yet available. The researchers plan to analyze how well the VMTech tool matches standard tests. They will look at agreement, sensitivity, and specificity. They will also compare cognitive scores between people with and without long COVID.
If the tool works, it could help doctors quickly identify who needs more support.
But there’s a catch
This is still early research. The tool is being validated, not yet used in clinics. The study is small and in one country. We don’t know if it will work for everyone.
This study addresses a real need. Faster cognitive screening could help more people get timely care. But it must be proven accurate and fair across different groups.
If you have brain fog after COVID, talk to your doctor. They can refer you for cognitive testing. This new tool is not available yet, but it shows promise for the future.
The study is small and cross-sectional. It cannot prove cause and effect. It only includes adults in one country. Results may not apply to children or other regions.
Next, researchers will complete the study and publish results. If the tool is validated, it may be tested in larger, more diverse groups. Approval for clinical use would take more time and evidence.
